SCHEMBL1747517

SCHEMBL1747517

CC(C)[C@@H](NC1=NCCN1)C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@H](C5CC5)N(C)C(=O)O)[nH]4)cc3)cc2)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.57
CYP2C9 P11712 4/20 0.57
NR1I2 O75469 2/20 0.57
KCNH2 Q12809 2/20 0.57
ABCB11 O95342 1/20 0.57
OPRK1 P41145 1/20 0.57
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 1/20 0.52
PRCP P42785 6/20 0.43
OPRM1 P35372 2/20 0.41
OPRD1 P41143 2/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1746981 0.92 CYP3A4 (0.59) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL1745687 0.91 CYP3A4 (0.59) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL1747509 0.91 CYP3A4 (0.59) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12159450 0.90 CYP3A4 (0.62) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL692493 0.89 CYP3A4 (0.64) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL691541 0.89 CYP3A4 (0.64) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL12159442 0.89 CYP3A4 (0.65) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL3341944 0.88 CYP3A4 (0.61) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL4527438 0.88 CYP3A4 (0.67) CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL4976569 0.88 CYP3A4 (0.67) CYP3A4CYP2C9NR1I2KCNH2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049522-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-05-14 EP claimed
EP-2385048-A1 Hepatitis C virus inhibitors Bristol-Myers Squibb Company (US) 2011-11-09 EP disclosed
US-20110252687-A1 Canting Vertical Fore Grip with Bipod GRIP POD SYSTEMS, LLC 2011-10-20 US disclosed